1. Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib. (22nd July 2021) Authors: Rapposelli, Ilario Giovanni; Tada, Toshifumi; Shimose, Shigeo; Burgio, Valentina; Kumada, Takashi; Iwamoto, Hideki; Hiraoka, Atsushi; Niizeki, Takashi; Atsukawa, Masanori; Koga, Hironori; Hirooka, Masashi; Torimura, Takuji; Iavarone, Massimo; Tortora, Raffaella; Campani, Claudia; Lonardi, Sara; T... Journal: Liver international Issue: Volume 41:Number 12(2021) Page Start: 2997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab. (14th December 2022) Authors: Tada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimu... Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 7772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis. Issue 2 (5th January 2021) Authors: Chuma, Makoto; Uojima, Haruki; Hiraoka, Atsushi; Kobayashi, Satoshi; Toyoda, Hidenori; Tada, Toshifumi; Hidaka, Hisashi; Iwabuchi, Shogo; Numata, Kazushi; Itobayashi, Ei; Itokawa, Norio; Kariyama, Kazuya; Ohama, Hideko; Hattori, Nobuhiro; Hirose, Shunji; Shibata, Hiroshi; Tani, Joji; Imai, Michit... Journal: Hepatology research Issue: Volume 51:Issue 2(2021) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis. Issue 5 (9th February 2022) Authors: Hatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishi... Journal: Hepatology research Issue: Volume 52:Issue 5(2022) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience. Issue 2 (11th June 2021) Authors: Hiraoka, Atsushi; Kumada, Takashi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimu... Journal: Cancer reports Issue: Volume 5:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023) Authors: Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamo... Journal: European journal of cancer Issue: Volume 180(2023) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ca2+/S100 proteins regulate HCV virus NS5A–FKBP8/FKBP38 interaction and HCV virus RNA replication. (24th March 2013) Authors: Tani, Joji; Shimamoto, Seiko; Mori, Kyoko; Kato, Nobuyuki; Moriishi, Kohji; Matsuura, Yoshiharu; Tokumitsu, Hiroshi; Tsuchiya, Mitsumasa; Fujimoto, Tomohito; Kato, Kiyohito; Miyoshi, Hisaaki; Masaki, Tsutomu; Kobayashi, Ryoji Journal: Liver international Issue: Volume 33:Number 7(2013:Aug.) Page Start: 1008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Can microRNA‐96‐5p serve as a therapeutic molecule in the near future?. Issue 1 (3rd January 2022) Authors: Masaki, Tsutomu; Tani, Joji; Morishita, Asahiro Journal: Hepatology research Issue: Volume 52:Issue 1(2022) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis. Issue 5 (7th September 2017) Authors: Toyoda, Hidenori; Hiraoka, Atsushi; Tada, Toshifumi; Michitaka, Kojiro; Takaguchi, Koichi; Tsuji, Kunihiko; Itobayashi, Ei; Takizawa, Daichi; Hirooka, Masashi; Koizumi, Yohei; Ochi, Hironori; Joko, Koji; Kisaka, Yoshiyasu; Shimizu, Yuko; Tajiri, Kazuto; Tani, Joji; Taniguchi, Tatsuya; Toshimori, ... Journal: Therapeutic apheresis and dialysis Issue: Volume 21:Issue 5(2017) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis. Issue 11 (8th October 2021) Authors: Himoto, Takashi; Yamamoto, Shuhei; Morimoto, Kaho; Tada, Satoshi; Mimura, Shima; Fujita, Koji; Tani, Joji; Morishita, Asahiro; Masaki, Tsutomu Journal: Journal of clinical laboratory analysis Issue: Volume 35:Issue 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗